Long-Term Care Resident Awareness and Interest in Spasticity Treatments

Area of Science:

• Neurology
• Geriatrics
• Rehabilitation Medicine

Background:

• Spasticity affects up to one-third of long-term care residents.
• Despite available FDA-approved therapies, spasticity remains under-treated in this population.
• Lack of awareness regarding treatment options may be a significant barrier.

Purpose of the Study:

• To assess awareness and interest in spasticity treatments among long-term care residents.
• To identify potential barriers to receiving spasticity treatment in veterans' home residents.

Main Methods:

• A cross-sectional study involving interviews with 18 nursing home and 11 veterans' home residents.
• Residents were surveyed on their awareness of spasticity treatments and interest after education.
• Veterans' home residents also reported on barriers to care.

Main Results:

• A majority of residents were unaware of most available spasticity treatments.
• Awareness was highest for physical/occupational therapy (83%) and lowest for intrathecal baclofen (21%).
• Post-education, significant interest in treatment emerged, with over a quarter becoming interested and one-fifth possibly interested.

Conclusions:

• Patient-centered education is crucial for improving spasticity treatment in long-term care.
• Addressing barriers such as travel and insurance knowledge is necessary.
• Discerning patient preferences can enhance treatment acceptance and adherence.